亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Time in range is a tool for assessing the quality of glycemic control in diabetes

血糖性 医学 标准化 连续血糖监测 糖尿病 临床实习 2型糖尿病 重症监护医学 计算机科学 内分泌学 物理疗法 操作系统
作者
Л. А. Суплотова,А. С. Судницына,Н. В. Романова,М. В. Шестакова
出处
期刊:Diabetes mellitus [UP Print]
卷期号:24 (3): 282-290 被引量:7
标识
DOI:10.14341/dm12703
摘要

The presence of continuous glucose monitoring (CGM) systems has expanded diagnostic capabilities. The implementation of this technology into clinical practice allowed to determine the patterns and tendencies of excursions in glucose levels, to obtain reliable data concerning short-term glycemic control. Taking into consideration the large amount of obtained information using CGM systems, more than 30 different indicators characterizing glycemic variability were proposed. However, it is very difficult for a practitioner to interpret the data obtained due to the variety of indicators and the lack of their target values. The first step in the standardization of indices was the creation of the International Guidelines for CGM in 2017, where the Time in Range (TIR) (3,9–10,0 mmol/l, less often 3,9–7,8 mmol/l) was significant. To complement the agreed parameters and simplify the interpretation of obtained data using CGM, in 2019 the recommendations were prepared for the International Consensus on Time in Range, where TIR was validated as an additional component of the assessment of glycemic control along with HbA 1c . In the literature review the issues of the association of TIR with the development of micro- and macrovascular complications in type 1 and 2 diabetes are considered. The relationship with other indicators of the glycemic control assessment was also analyzed and the dependence of insulin therapy on TIR was shown. TIR is a simple and convenient indicator, it has a proven link with micro- and macrovascular complications of diabetes and can be recommended as a new tool for assessing the glycemic control. The main disadvantage of TIR usage is the insufficient apply of CGM technology by the majority of patients with diabetes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小狗发布了新的文献求助10
5秒前
金枪鱼子完成签到,获得积分10
6秒前
量子星尘发布了新的文献求助10
19秒前
FIN应助小河向东流采纳,获得10
22秒前
Perion完成签到 ,获得积分10
23秒前
我是老大应助rrrrry采纳,获得10
41秒前
隐形曼青应助xx采纳,获得10
1分钟前
1分钟前
1分钟前
轩辕山槐完成签到,获得积分10
1分钟前
1分钟前
rrrrry发布了新的文献求助10
1分钟前
Rondab应助科研通管家采纳,获得10
1分钟前
Rondab应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
Rondab应助科研通管家采纳,获得10
1分钟前
Rondab应助科研通管家采纳,获得10
1分钟前
cc应助科研通管家采纳,获得10
1分钟前
Rondab应助科研通管家采纳,获得10
1分钟前
Rondab应助科研通管家采纳,获得10
1分钟前
cc应助科研通管家采纳,获得10
1分钟前
1分钟前
Rondab应助科研通管家采纳,获得10
1分钟前
11完成签到,获得积分10
1分钟前
2分钟前
量子星尘发布了新的文献求助10
2分钟前
11发布了新的文献求助10
2分钟前
麦兜完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
雪花精灵发布了新的文献求助10
2分钟前
xicifish完成签到,获得积分10
2分钟前
CodeCraft应助雪花精灵采纳,获得10
2分钟前
hgsgeospan完成签到,获得积分10
2分钟前
hgs完成签到,获得积分10
2分钟前
张晓祁完成签到,获得积分10
2分钟前
逆天大脚完成签到,获得积分10
3分钟前
yueying完成签到,获得积分10
3分钟前
3分钟前
xicifish发布了新的文献求助10
3分钟前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3960053
求助须知:如何正确求助?哪些是违规求助? 3506261
关于积分的说明 11128558
捐赠科研通 3238254
什么是DOI,文献DOI怎么找? 1789617
邀请新用户注册赠送积分活动 871829
科研通“疑难数据库(出版商)”最低求助积分说明 803056